Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in Relapsed/Refractory Multiple Myeloma
NCT02509052Phase 2Completed
- Sponsor
- City of Hope
- Start
- Dec 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflunomide in multiple myeloma (MM), sponsored by City of Hope. Started Dec 2015; status: completed.
02
Drugs
leflunomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02509052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509052.